Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2022-07-01 00:00:00 ET · period of report 2022-06-29 · accession 0001209191-22-040343 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-01 | 2022-06-29 | CRSP | Kulkarni Samarth | CEO, Dir | S - Sale+OE | $61.59 | -25.0K | 290.3K | -8% | -$1.54M |
| D | 2022-07-01 | 2022-06-29 | CRSP | Kulkarni Samarth | CEO, Dir | M - OptEx | $12.57 | +25.0K | 315.3K | +9% | +$314.2K |
| D | 2022-07-01 | 2022-06-29 | CRSP | Kulkarni Samarth | CEO, Dir | M - OptEx | $0.00 | -25.0K | 8,333 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-06-29 | S | D | 20,260 | $61.42 | 295,019 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.99 to $61.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Shares | 2022-06-29 | M | A | 25,000 | $12.57 | 315,279 | D | — | — | |
| 3 | Common | Common Shares | 2022-06-29 | S | D | 4,740 | $62.32 | 290,279 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-06-29 | M | D | 25,000 | $0.00 | 8,333 | D | $12.57 · — to 2026-07-15 | 25,000 Common Shares | (F4) This option was granted on July 15, 2016 with respect to 93,333 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016. |